Cell Ongrowth and Biocompatibility Study of Two Different (Hydrophobic Acrylic) Intraocular Lenses: IOL XY1 vs. IOL XY1A

Medical University of Vienna

Status

Completed

Conditions

Cataract

Treatments

Procedure: cataract surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT06708806

HOPP

2060/2019

Details and patient eligibility

About

The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Cataract surgery with precedent bilateral randomized IOL implantation will be performed in subjects who have signed an informed consent form. Postoperative examinations will be implemented in accordance with the approved investigational plan.

Enrollment

50 patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Bilateral age-related cataract for which phacoemulsification extraction and posterior IOL implantation is planned
Age 40 and older
Astigmatism of at least 0.75Diopters in one eye
Normal findings in medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant

Exclusion criteria

Diabetes mellitus
Pseudoexfoliation syndrome
Systemical anticoagulation
Antiphlogistic therapy
Antiglaucomatosa
Uncontrolled systemic or ocular disease
Preceding ocular surgery or trauma
Intraoperative complications
Pregnancy/Nursing
Concurrently participating in any other clinical trial or if they have participated in any other clinical trial during the last 30 days